CLINICAL PREDICTORS OF RESPONSE TO NALTREXONE IN ALCOHOLIC PATIENTS: WHO BENEFITS MOST FROM TREATMENT WITH NALTREXONE?
Open Access
- 29 March 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 40 (3) , 227-233
Abstract
Aims: To determine the clinically ascertained variables that are related to satisfactory response to naltrexone (NTX) treatment of alcohol dependence after detoxification. Methods: The use of intake and outcome variables were measured in a randomized 3-month open-controlled trial comparing the effects of naltrexone plus psychotherapy treatment versus psychotherapy treatment alone on the maintenance of abstinence in the final 28 days ( n = 336, all male). Results: Predictors of a positive response to NTX treatment were family history of alcoholism ( P = 0.010), early age at onset of drinking problems ( P = 0.014) and comorbid use of other drugs of abuse ( P < 0.001). Among the subjects not treated with NTX, the greater the number of predictor variables, the lower the final 28 days abstinence rates ( P = 0.00003), but this was not the case in patients treated with NTX ( P = 0.844). Conclusions: Patients with these features, suggesting biological vulnerability overall have poorer outcomes, but this can be reduced with NTX treatment. The type of alcoholism should be considered before deciding on the pharmacological strategy.Keywords
This publication has 34 references indexed in Scilit:
- A 6‐Month Controlled Naltrexone Study: Combined Effect With Cognitive Behavioral Therapy in Outpatient Treatment of Alcohol DependenceAlcohol, Clinical and Experimental Research, 2003
- Targeted Naltrexone for Early Problem DrinkersJournal of Clinical Psychopharmacology, 2003
- Naltrexone in the Treatment of Alcohol DependenceNew England Journal of Medicine, 2001
- Naltrexone for alcohol dependence: a randomized controlled trialAddiction, 2001
- Predicting Treatment Response to Naltrexone: The Influence of Craving and Family HistoryThe American Journal on Addictions, 2001
- Differences in the Brain and Pituitary β‐Endorphin System between the Alcohol‐Preferring AA and Alcohol‐Avoiding ANA RatsAlcohol, Clinical and Experimental Research, 1992
- Different pituitary ß-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholismLife Sciences, 1989
- Cellular and Molecular Mechanisms of Drug DependenceScience, 1988
- Genetic Heterogeneity and the Classification of AlcoholismAdvances in Alcohol & Substance Abuse, 1988
- Naltrexone blocks the post-shock increase of ethanol consumptionLife Sciences, 1986